InTandem Capital Partners has announced it has completed an investment in OrthoNebraska.
OrthoNebraska, based in Omaha, Neb., is a regional provider of orthopedic and musculoskeletal care. Founded in 2004, the organization has locations in Nebraska, Iowa and Missouri that provide surgical and non-surgical intervention, supported by a range of sub-specialized providers.
InTandem, based…
Coalesce Capital has announced it has participated in a recapitalization of Examinetics.
Examinetics, founded in 2004 and based in Overland Park, Kan., is a provider of mobile occupational health screening services, tests and data management.
Coalesce, based in New York, is a middle market private equity firm focused on investing in human capital…
BV Investment Partners has announced it has invested in Hardenbergh Group.
Hardenbergh Group, founded in 1991 and based in Livonia, Mich., is a provider of non-clinical professional staffing, consulting, physician peer review and outsourced solutions to U.S. healthcare organizations.
BV, based in Boston, is a middle market private equity firm focused on the…
Kohlberg & Company will acquire Worldwide Clinical Trials, according to a news release.
Worldwide, based in Research Triangle Park, N.C., is a full-service contract research organization. Founded in 1986, Worldwide, an affiliate company of private equity firm TJC, partners with biotechnology and pharmaceutical companies to create solutions designed to advance new medications.
Despite a decline in overall senior housing M&A activity from 2022 to 2023, nonprofit M&A is pacing for a record year.[1] Many of the same market conditions that cooled overall M&A activity — such as increasing interest rates, tightened lending requirements and operational uncertainty — appear to be causing a surge in nonprofit affiliations,…
Since mid-2022, the macro acquisition environment has faced the challenges of inflation and increasing interest rates, among a variety of other headwinds. Global deal flow is down from its 2021 peak. Yet, as this white paper will explain at a granular level, private equity investment in healthcare companies remains a viable and, in some cases,…
SK Capital Partners has announced it has closed its latest fund with $800 million in commitments.
The new fund, SKCP Catalyst Fund II, was oversubscribed. It will focus on buyout investments that generally require initial committed equity capital of up to $100 million.
SK Capital Partners, based in New York, is a private equity…
WM Partners recently announced it had acquired Allergy Research Group (ARG) from Kikkoman Corp.
ARG, founded in 1979 and based in South Salt Lake, Utah, sells hypoallergenic supplements focused on addressing condition-specific issues to healthcare practitioners.
WM Partners, based in Aventura, Fla., is a middle-market private equity firm. Founded in 2015, the firm…
Audax Private Equity recently announced it closed two new funds with a combined $7.8 billion.
Audax Private Equity Fund VII was oversubscribed, hitting its hard cap of $5.25 billion.
Audax Private Equity Origins Fund I closed with $774 million, exceeding its initial target. This fund is the firm’s first lower middle market strategy.
When combined…
Comvest Partners has announced it has closed its latest fund at $2 billion.
The new fund, Comvest Credit Partners VI, exceeded its initial target of $1.7.
Comvest, based in West Palm Beach, Fla., is a middle-market private equity and credit investing firm. Its private equity strategy is to pursue control investments in multiple industries,…
